| P50 | author | Bogusław Tomanek | Q55447361 |
| P2093 | author name string | Hélène Perreault | |
| | Vic Spicer | |
| | Erika Lattová | |
| | Dorota Bartusik | |
| | Julia Jellusova | |
| P2860 | cites work | Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism? | Q36613598 |
| | Post-translational modifications in the context of therapeutic proteins | Q36620451 |
| | Analytical performance of immobilized pronase for glycopeptide footprinting and implications for surpassing reductionist glycoproteomics | Q37087199 |
| | Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action | Q37529994 |
| | Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types | Q38308978 |
| | Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer. | Q40001571 |
| | A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients | Q40158443 |
| | Expression of her-2/neu on acute lymphoblastic leukemias: implications for the development of immunotherapeutic approaches | Q40636935 |
| | Simultaneous glycan-peptide characterization using hydrophilic interaction chromatography and parallel fragmentation by CID, higher energy collisional dissociation, and electron transfer dissociation MS applied to the N-linked glycoproteome of Campy | Q42589849 |
| | Electrospray ionization quadrupole ion-mobility time-of-flight mass spectrometry as a tool to distinguish the lot-to-lot heterogeneity in N-glycosylation profile of the therapeutic monoclonal antibody trastuzumab. | Q43278365 |
| | Glycosylation of antibody therapeutics: optimisation for purpose | Q43549121 |
| | Electron capture dissociation and infrared multiphoton dissociation MS/MS of an N-glycosylated tryptic peptic to yield complementary sequence information | Q43749887 |
| | Systematic LC-MS analysis of labile post-translational modifications in complex mixtures | Q46089218 |
| | Tumor-associated sialylated antigens are constitutively expressed in normal human colonic mucosa | Q71690153 |
| | GlycoPep DB: a tool for glycopeptide analysis using a "Smart Search" | Q79768632 |
| | Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. | Q27824766 |
| | Chemical glycobiology | Q28206826 |
| | Proposal for a common nomenclature for sequence ions in mass spectra of peptides | Q28269961 |
| | Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides | Q28288481 |
| | Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer | Q29616112 |
| | Determination of optimal freezing parameters of human prostate cancer in a nude mouse model | Q30473150 |
| | A tandem quadrupole/time-of-flight mass spectrometer with a matrix-assisted laser desorption/ionization source: design and performance | Q30881756 |
| | Matrix-assisted laser desorption/ionization tandem mass spectrometry and post-source decay fragmentation study of phenylhydrazones of N-linked oligosaccharides from ovalbumin | Q33202537 |
| | Profiling analysis of oligosaccharides in antibody pharmaceuticals by capillary electrophoresis | Q33208374 |
| | Method for investigation of oligosaccharides from glycopeptides: direct determination of glycosylation sites in proteins | Q33241355 |
| | Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys | Q33276349 |
| | Matrix-assisted laser desorption/ionization on-target method for the investigation of oligosaccharides and glycosylation sites in glycopeptides and glycoproteins | Q33283012 |
| | A two-dimensional array for simultaneous sequencing of N- and o-glycans and their glycoforms on specific glycosylation sites | Q33315430 |
| | Characterization of N-linked glycosylation on recombinant glycoproteins produced in Pichia pastoris using ESI-MS and MALDI-TOF. | Q33416895 |
| | Mass spectrometric study of N-glycans from serum of woodchucks with liver cancer | Q33494109 |
| | Combined treatment of human MCF-7 breast carcinoma with antibody, cationic lipid and hyaluronic acid using ex vivo assays | Q33497074 |
| | N-glycomic changes in human breast carcinoma MCF-7 and T-lymphoblastoid cells after treatment with herceptin and herceptin/Lipoplex | Q33523126 |
| | Ex vivo assays of CEM cells cultured and treated in the three dimensional cultures | Q33546897 |
| | Mass spectrometric identification of aberrantly glycosylated human apolipoprotein C-III peptides in urine from Schistosoma mansoni-infected individuals | Q33812839 |
| | From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines Frequently used abbreviations are listed in the appendix | Q33889202 |
| | Protein glucosylation and its role in protein folding | Q34019347 |
| | Non-viral gene delivery for p53. | Q34182687 |
| | Combining trastuzumab (Herceptin) with hormonal therapy in breast cancer: what can be expected and why? | Q35590094 |
| | Glycosylation of recombinant antibody therapeutics | Q36132495 |
| | Trastuzumab: updates and future issues | Q36307436 |
| P433 | issue | 9 | |
| P921 | main subject | breast carcinoma | Q18555947 |
| P304 | page(s) | M111.007765 | |
| P577 | publication date | 2011-05-24 | |
| P1433 | published in | Molecular & Cellular Proteomics | Q6895932 |
| P1476 | title | Alterations in glycopeptides associated with herceptin treatment of human breast carcinoma mcf-7 and T-lymphoblastoid cells | |
| P478 | volume | 10 | |